The cardioprotective effects of erythropoietin in myocardial ischemic injury via upregulation of SDF-1 by JAK2/STAT3

International Journal of Cardiology

Volumn 156, Issue 3, 2012, Pages 320-322

  Wang, Xiaoyan ^a   Chen, Yaobin ^a   Kuang, Dong ^a   Zhang, Lili ^a   She, Tonghui ^a   Jie, Wei ^a   Zhao, Xia ^a   Ao, Qilin ^a   Wang, Guoping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Erythropoietin; Myocardial infarction; SDF 1; STAT3

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ERYTHROPOIETIN; JANUS KINASE 2; STAT3 PROTEIN; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CARDIOVASCULAR PARAMETERS; CELL TYPE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FIBROBLAST; GENETIC TRANSCRIPTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LETTER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VESSEL DENSITY;

EID: 84862810068     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.102     Document Type: Article

References (8)

1. Calvillo L, Latini R, Kajstura J, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003;100:4802-6. (Pubitemid 36457809)
2. Wang Lei, Zhang Zheng Gang, Zhang Rui Lan, et al. Matrix metalloproteinase2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 2006;26:5996-6003.
3. Parsa CJ, Matsumoto A, Kim J, et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003;112:999-1007. (Pubitemid 38056315)
4. Tada H, Kagaya Y, Takeda M, et al. Endogenous erythropoietin system in nonhematopoietic lineage cells plays a protective role in myocardial ischemia/ reperfusion. Cardiovasc Res 2006;71:466-77. (Pubitemid 44107864)
5. Westenbrink BD, LE, van der Meer P, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularisation. Eur Heart J 2007;28:2018-27.
6. Su Hua, Takagawa Junya, Huang Yu, et al. Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart. Int J Cardiol 2009;133:191-7.
7. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110:3300-5. (Pubitemid 39557491)
8. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stemcell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697-703. (Pubitemid 37101067)